NEUP · Categories · Form 4

NEUP - SEC Form 4 insider transactions

Neuphoria Therapeutics Inc. (NEUP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NEUP

• 95d
  SEC Form 4 filed by Director Wilson David Ian

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 95d
  SEC Form 4 filed by Director Davies Peter Miles Winston

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 95d
  SEC Form 4 filed by Director Fisher Alan

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 95d
  SEC Form 4 filed by Director Ryan Jane

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 236d
  SEC Form 4 filed by President and CEO Papapetropoulos Spyros

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 342d
  Amendment: SEC Form 4 filed by President and CEO Papapetropoulos Spyros

  4/A - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by President and CEO Papapetropoulos Spyros

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by Director Davies Peter Miles Winston

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by Director Ryan Jane

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by Director Wilson David Ian

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by Director Fisher Alan

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)

Other NEUP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends